Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans
There are four dengue virus (DENV) serotypes. Primary infection with one does not confer protective immunity against the others. We have reported previously that the marmoset (Callithrix jacchus) is a useful primary DENV infection model. It has been reported that secondary DENV infection with a heterotypic serotype induces viraemia kinetics and antibody responses that differ from those in primary infection. Thus, it is important to determine the utility of the marmoset as a model for secondary DENV infection. Marmosets were infected with heterologous DENV by secondary inoculation, and viraemia kinetics and antibody responses were analysed. The marmosets consistently developed high levels of viraemia after the secondary inoculation with heterologous DENV serotypes. IgM responses were lower compared with primary inoculation responses, whilst IgG responses were rapid and high. Neutralizing activities, which possessed serotype cross-reactive activities, were detected as early as 4 days after inoculation. In addition, infectious viraemia titres were higher when assayed with Fcγ receptor-expressing baby hamster kidney (BHK) cells than when assayed with conventional BHK cells, suggesting the presence of infectious virus–antibody immune complexes. After secondary infection with heterotypic DENV, the marmosets demonstrated viraemia kinetics, IgM and IgG responses, and high levels of serotype cross-reactive neutralizing antibody responses, all of which were consistent with secondary DENV infection in humans. The results indicate the marmoset as a useful animal for studying secondary, as well as primary, DENV infection.
AnantapreechaS.,
ChanamaS.,
A-nuegoonpipatA.,
NaemkhunthotS.,
Sa-NgasangA.,
SawanpanyalertP.,
KuraneI.2005; Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002. Epidemiol Infect 133:503–507 [View Article][PubMed]
BernardoL.,
IzquierdoA.,
PradoI.,
RosarioD.,
AlvarezM.,
SantanaE.,
CastroJ.,
MartínezR.,
RodríguezR.other authors2008; Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2. Clin Vaccine Immunol 15:439–446 [View Article][PubMed]
BhattS.,
GethingP. W.,
BradyO. J.,
MessinaJ. P.,
FarlowA. W.,
MoyesC. L.,
DrakeJ. M.,
BrownsteinJ. S.,
HoenA. G.other authors2013; The global distribution and burden of dengue. Nature 496:504–507 [View Article][PubMed]
ClarkK. B.,
OnlamoonN.,
HsiaoH. M.,
PerngG. C.,
VillingerF.2013; Can non-human primates serve as models for investigating dengue disease pathogenesis?. Front Microbiol 4:305[PubMed]
GublerD. J.,
RosenL.1976; A simple technique for demonstrating transmission of dengue virus by mosquitoes without the use of vertebrate hosts. Am J Trop Med Hyg 25:146–150[PubMed]
GuyB.,
BarbanV.,
MantelN.,
AguirreM.,
GuliaS.,
PontvianneJ.,
JourdierT. M.,
RamirezL.,
GregoireV.other authors2009; Evaluation of interferences between dengue vaccine serotypes in a monkey model. Am J Trop Med Hyg 80:302–311[PubMed]
GuzmanM. G.,
AlvarezM.,
HalsteadS. B.2013; Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 158:1445–1459 [View Article][PubMed]
HalsteadS. B.,
ShotwellH.,
CasalsJ.Clinical Laboratory Responses to Heterologous Infection1973a; Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J Infect Dis 128:15–22 [View Article][PubMed]
HalsteadS. B.,
CasalsJ.,
ShotwellH.,
PalumboN.1973b; Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Am J Trop Med Hyg 22:365–374[PubMed]
KorakaP.,
BentonS.,
van AmerongenG.,
StittelaarK. J.,
OsterhausA. D.2007a; Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques. Vaccine 25:5409–5416 [View Article][PubMed]
KorakaP.,
BentonS.,
van AmerongenG.,
StittelaarK. J.,
OsterhausA. D. M. E.2007b; Characterization of humoral and cellular immune responses in cynomolgus macaques upon primary and subsequent heterologous infections with dengue viruses. Microbes Infect 9:940–946 [View Article][PubMed]
MarchetteN. J.,
HalsteadS. B.,
FalklerW. A.Jr,
StenhouseA.,
NashD.1973; Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J Infect Dis 128:23–30 [View Article][PubMed]
MoiM. L.,
LimC. K.,
KotakiA.,
TakasakiT.,
KuraneI.2011; Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection. J Infect Dis 203:1405–1414 [View Article][PubMed]
MoiM. L.,
OmatsuT.,
HirayamaT.,
NakamuraS.,
KatakaiY.,
YoshidaT.,
SaitoA.,
TajimaS.,
ItoM.other authors2013; Presence of viral genome in urine and development of hematuria and pathological changes in kidneys in common marmoset (Callithrix jacchus) after inoculation with dengue virus. Pathogens 2:357–363 [View Article]
OmatsuT.,
MoiM. L.,
HirayamaT.,
TakasakiT.,
NakamuraS.,
TajimaS.,
ItoM.,
YoshidaT.,
SaitoA.other authors2011; Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J Gen Virol 92:2272–2280 [View Article][PubMed]
OmatsuT.,
MoiM. L.,
TakasakiT.,
NakamuraS.,
KatakaiY.,
TajimaS.,
ItoM.,
YoshidaT.,
SaitoA.other authors2012; Changes in hematological and serum biochemical parameters in common marmosets (Callithrix jacchus) after inoculation with dengue virus. J Med Primatol 41:289–296 [View Article][PubMed]
RothmanA. L.2010; Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr Top Microbiol Immunol 338:83–98[PubMed]
SchererW. F.,
BreakenridgeF. A.,
DickermanR. W.1972; Cross-protection studies and search for subclinical disease in New World monkeys infected sequentially with different immunologic types of dengue viruses. Am J Epidemiol 95:67–79[PubMed]
SchererW. F.,
RussellP. K.,
RosenL.,
CasalsJ.,
DickermanR. W.1978; Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg 27:590–599[PubMed]
SchiavettaA. M.,
HarreJ. G.,
WagnerE.,
SimmonsM.,
RaviprakashK.2003; Variable susceptibility of the owl monkey (Aotus nancymae) to four serotypes of dengue virus. Contemp Top Lab Anim Sci 42:12–20[PubMed]
ShrestaS.,
ShararK. L.,
PrigozhinD. M.,
BeattyP. R.,
HarrisE.2006; Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol 80:10208–10217 [View Article][PubMed]
StyerL. M.,
KentK. A.,
AlbrightR. G.,
BennettC. J.,
KramerL. D.,
BernardK. A.2007; Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog 3:1262–1270[PubMed][CrossRef]
TanG. K.,
NgJ. K.,
TrastiS. L.,
SchulW.,
YipG.,
AlonsoS.2010; A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. PLoS Negl Trop Dis 4:e672 [View Article][PubMed]
VaughnD. W.,
WhiteheadS. S.,
DurbinA.2008; Viral vaccines. In Vaccines for Biodefense and Emerging and Neglected Diseases pp. 302–304 Edited by
BarrettA. D. T.,
StanberryL. R.
London: Academic Press, Elsevier;
WeiskopfD.,
YauchL. E.,
AngeloM. A.,
JohnD. V.,
GreenbaumJ. A.,
SidneyJ.,
KollaR. V.,
De SilvaA. D.,
de SilvaA. M.other authors2011; Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. J Immunol 187:4268–4279 [View Article][PubMed]
Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans